Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional Plasticity Drives IMiD and p300 Inhibitor Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 38085608 | PubTator, text mining | PubMed |
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| FOXP3-regulated lncRNA NONHSAT136151 promotes colorectal cancer progression by disrupting QKI interaction with target mRNAs. | J Cell Mol Med | 2024 | 38041531 | PubTator, text mining | PubMed |
| Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer. | Genes Genomics | 2024 | 38032469 | PubTator, text mining | PubMed |
| Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq. | Adv Sci (Weinh) | 2024 | 38010945 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
| RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities. | Genes Dis | 2024 | 37692504 | PubTator, text mining | PubMed |
| Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation. | Chin Med J (Engl) | 2024 | 37660289 | PubTator, text mining | PubMed |
| The Mediating Role of miR-451/ETV4/MMP13 Signaling Axis on Epithelialmesenchymal Transition in Promoting Non-small Cell Lung Cancer Progression. | Curr Mol Pharmacol | 2024 | 37489792 | PubTator, text mining | PubMed |
| There and back again: 50 years of wandering through terra incognita fusorum. | Exp Physiol | 2024 | 36628601 | PubTator, text mining | PubMed |
| Ehf and Fezf2 regulate late medullary thymic epithelial cell and thymic tuft cell development. | Front Immunol | 2023 | 38420512 | PubTator, text mining | PubMed |
| Transcription factor-target gene regulatory network analysis in human lung adenocarcinoma. | J Thorac Dis | 2023 | 38249888 | PubTator, text mining | PubMed |
| Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma. | Front Pharmacol | 2023 | 38239197 | PubTator, text mining | PubMed |
| Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer. | Res Sq | 2023 | 38234761 | PubTator, text mining | PubMed |
| Neural cell diversity in the light of single-cell transcriptomics. | Transcription | 2023 | 38229529 | PubTator, text mining | PubMed |
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection. | Int J Mol Sci | 2023 | 38203551 | PubTator, text mining | PubMed |
| Actionable Driver Events in Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38203275 | PubTator, text mining | PubMed |
| Ferroptosis, Metabolic Rewiring, and Endometrial Cancer. | Int J Mol Sci | 2023 | 38203246 | PubTator, text mining | PubMed |
| Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis. | Front Microbiol | 2023 | 38188582 | PubTator, text mining | PubMed |
| Identifying the programmed cell death index of hepatocellular carcinoma for prognosis and therapy response improvement by machine learning: a bioinformatics analysis and experimental validation. | Front Immunol | 2023 | 38170006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=8